antidepressant

(redirected from Novel antidepressant)
Also found in: Thesaurus, Medical, Encyclopedia.

an·ti·de·pres·sant

 (ăn′tē-dĭ-prĕs′ənt, ăn′tī-)
n.
A drug used to treat depression.

an′ti·de·pres′sant, an′ti·de·pres′sive (-prĕs′ĭv) adj.

antidepressant

(ˌæntɪdɪˈprɛsənt)
n
(Pharmacology) any of a class of drugs used to alleviate depression
adj
(Pharmacology) of or relating to this class of drugs

an•ti•de•pres•sant

(ˌæn ti dɪˈprɛs ənt, ˌæn taɪ-) also

an•ti•de•pres•sive

(ˌæn ti dɪˈprɛs ɪv, ˌæn taɪ-)

adj.
1. used to relieve or treat mental depression.
n.
2. an antidepressant drug.
[1960–65]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.antidepressant - any of a class of drugs used to treat depressionantidepressant - any of a class of drugs used to treat depression; often have undesirable side effects
medicament, medication, medicinal drug, medicine - (medicine) something that treats or prevents or alleviates the symptoms of disease
MAOI, monoamine oxidase inhibitor - any of a group of antidepressant drugs that inhibit the action of monoamine oxidase in the brain and so allow monoamines to accumulate
nefazodone, Serzone - an antidepressant drug (trade name Serzone)
nontricyclic, nontricyclic antidepressant, nontricyclic antidepressant drug, nontricyclic drug - a class of antidepressant drugs that are not tricyclic drugs and do not act by inhibiting MAO
Edronax, reboxetine - an antidepressant drug that blocks the reuptake of norepinephrine
selective-serotonin reuptake inhibitor, SSRI - an antidepressant drug that acts by blocking the reuptake of serotonin so that more serotonin is available to act on receptors in the brain
tricyclic, tricyclic antidepressant, tricyclic antidepressant drug - an antidepressant drug that acts by blocking the reuptake of norepinephrine and serotonin and thus making more of those substances available to act on receptors in the brain
maleate - a salt or ester of maleic acid; used as a nontricyclic antidepressant drug for psychomotor activation
Translations
antidepresívum
antidepressivt middel
masennuslääke
antidepresiv
抗鬱剤
항울제
antidepressivt medel
ยาต้านอาการเศร้าซึม
thuốc chống trầm cảm

antidepressant

[ˌæntɪdɪˈpresnt]
A. ADJantidepresivo
B. Nantidepresivo m

antidepressant

مُضاد للِاكْتِئاب antidepresívum antidepressivt middel Antidepressivum αντικαταθλιπτικό antidepresivo masennuslääke antidépresseur antidepresiv antidepressivo 抗鬱剤 항울제 antidepressivum antidepressiva środek przeciwdepresyjny antidepressivo антидепрессант antidepressivt medel ยาต้านอาการเศร้าซึม antidepresan thuốc chống trầm cảm 抗抑郁剂

an·ti·de·pres·sant

n. antidepresivo, medicamento o proceso curativo usado para evitar estados de depresión.

antidepressant

adj & n antidepresivo; tricyclic — antidepresivo tricíclico
References in periodicals archive ?
As is true for the identification of many novel antidepressant agents, the antidepressant properties of anti-IL-6 antibody were not identified due to its biological functions but, rather, by observant clinicians focused on another problem.
Identification of the cytochrome P450 and other enzymes involved in the in vitro oxidative metabolism of a novel antidepressant, Lu AA21004.
ORLANDO -- The novel antidepressant vortioxetine proved safe, effective, and well tolerated for treatment of major depressive disorder specifically in elderly patients in a combined analysis of nine randomized, placebo-controlled clinical trials.
CPI-300 is a novel antidepressant with a high strength of bupropion hydrochloride (HCl), which is the active ingredient in Wellbutrin XL.
that Clinical Data is developing with a companion biomarker, which will act as a genetic-based, predictive screening tool to guide the use of the novel antidepressant.
Vortioxetine, a novel antidepressant, has been approved for treating major depressive disorder in adults.
Major finding: Patients with depression who did not respond adequately to a course of selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor therapy and who were then switched to double-blind treatment with the novel antidepressant vortioxetine had a 55% remission rate after 8 weeks of therapy.